Picture of enGene Therapeutics logo

ENGN enGene Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: enGene Reports First Quarter 2026 Financial Results and Provides Business Update

March 9 (Reuters) - enGene Holdings Inc ENGN.O:

ENGENE REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

ENGENE HOLDINGS Q1 NET LOSS $0.44 PER SHARE

Source text: ID:nBw1VS3cwa

Further company coverage: ENGN.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on enGene Therapeutics

See all news